Compare Cytokinetics Inc (CYTK) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Kinder Morgan Inc — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.63B), while Kinder Morgan Inc trades at $31.6 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 6.6× Cytokinetics Inc's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | KMI | |
|---|---|---|
Market Cap | $10.63B | $70.10B |
Sector | Technology | Energy |
52-Week High | $87.26 | $34.31 |
52-Week Low | $34.31 | $25.84 |
Enterprise Value | $10.74B | $102.15B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
